Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Rapid Micro Biosystems, Inc. (RPID) AI Forecast

Our AI analyzed Rapid Micro Biosystems, Inc.. Create a free account to see the 90-day price prediction.

Free account • 30-day free trial

$RPID Neutral Signal Full forecast available

Rapid Micro Biosystems, Inc. (RPID) Stock Forecast 2025


Rapid Micro Biosystems, Inc. (RPID) AI Stock Price Forecast & Investment Analysis

Rapid Micro Biosystems, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Rapid Micro Biosystems, Inc. (RPID) - Comprehensive Stock Analysis & Investment Research

Deep dive into Rapid Micro Biosystems, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 3, 2026, 10:52 a.m. (UTC)

Rapid Micro Biosystems, Inc. Investment Summary

When evaluating whether Rapid Micro Biosystems, Inc. (RPID) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Rapid Micro Biosystems, Inc. (RPID) operates within the Industrial Applications and Services sector, specifically in the Laboratory Analytical Instruments industry. The company employs approximately 196 people. With a market capitalization of $193 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Rapid Micro Biosystems, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Rapid Micro Biosystems, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Rapid Micro Biosystems, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Rapid Micro Biosystems, Inc.

Sign Up Free
Corporate Identity

Rapid Micro Biosystems, Inc. (Stock Symbol: RPID) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Laboratory Analytical Instruments industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Rapid Micro Biosystems, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Rapid Micro Biosystems, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Rapid Micro Biosystems, Inc....

Unlock Full Company Profile

Get complete details about Rapid Micro Biosystems, Inc.

Sign Up Free
Revenue & Growth Analysis

Rapid Micro Biosystems, Inc. generates annual revenues of $30 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Rapid Micro Biosystems, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Rapid Micro Biosystems, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Rapid Micro Biosystems, Inc....

Unlock Financial Analysis

Get complete financial metrics for Rapid Micro Biosystems, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Rapid Micro Biosystems, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Rapid Micro Biosystems, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Rapid Micro Biosystems, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-66 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Margin & Pricing Power Analysis

The company maintains a -45.8% gross margin characteristic of commodity-like businesses or high-volume, low-margin operators. Thin gross margins require exceptional operational efficiency and volume to generate meaningful profits. Companies at this margin level are particularly sensitive to cost increases or pricing pressures.

Operating margin of -141.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Asset Utilization Efficiency

Asset turnover ratio of 0.12x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 12.57 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Rapid Micro Biosystems, Inc. (RPID) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Rapid Micro Biosystems, Inc. stock analysis.

Deep dive into Rapid Micro Biosystems, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Rapid Micro Biosystems, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Rapid Micro Biosystems, Inc.: With a P/E ratio of -0.87, the market sees the stock as potentially undervalued.

P/E Ratio -0.87x
P/B Ratio 4.35x
Market Cap $193M
EPS $-1.00
Book Value/Share $1.00
Revenue/Share $0.69
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Rapid Micro Biosystems, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Rapid Micro Biosystems, Inc.: An ROE of -245.1% indicates room for improvement in shareholder value creation.

ROE -245.1%
ROA -37.2%
ROIC -151.0%
Gross Margin -45.8%
Operating Margin -141.8%
Net Margin -133.7%
EBT Margin -295.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Rapid Micro Biosystems, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Rapid Micro Biosystems, Inc.: A current ratio of 12.57 indicates strong liquidity.

Current Ratio 12.57x
Quick Ratio 11.18x
D/E Ratio 0.04x
Financial Leverage 1.11x
Interest Coverage -37.3x
Working Capital $47M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Rapid Micro Biosystems, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Rapid Micro Biosystems, Inc.: Free cash flow of $-66M indicates cash challenges that need attention.

Operating Cash Flow -$61M
Free Cash Flow -$66M
Capital Spending -$5M
FCF/Sales -293.9%
CapEx/Sales 23.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Rapid Micro Biosystems, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Rapid Micro Biosystems, Inc.: An asset turnover of 0.12x suggests room for improvement in asset utilization.

Asset Turnover 0.12x
Receivables Turnover 5.9x
Inventory Turnover 2.2x
Fixed Assets Turnover 1.7x
Days Sales Outstanding 62 days
Days Inventory 167 days
Payables Period 39 days
Cash Conversion Cycle 190 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Rapid Micro Biosystems, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Rapid Micro Biosystems, Inc.: With annual revenue of $30M, Rapid Micro Biosystems, Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $30M
R&D Expense $15M
SG&A Expense $151M
Cost of Goods Sold $42M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 81%
Cash & Short-term Investments 71%
Total Liabilities 10%
Accounts Receivable 2%
Inventory 8%
Dividend & Shareholder Information
Shares Outstanding 45M
Growth Metrics (YoY)
EPS Growth -85.2%

Latest Rapid Micro Biosystems, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Rapid Micro Biosystems, Inc. (RPID) stock price and investment outlook.

More news available

Sign up free to read all 9 news articles and stay updated on market developments.

Sign Up Free to Read More

Rapid Micro Biosystems, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Rapid Micro Biosystems, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Agilent Technologies, Inc. A ██% $33.45B 25.7x 5.0x
Astrotech Corp ASTC ██% $5M 28.9x 0.3x
Avantor, Inc. AVTR ██% $6.18B 15.5x 1.1x
Bioforce Nanosciences Holdings, Inc. BFNH ██% $17M x 2345.5x
Bio-Rad Laboratories, Inc. BIO ██% $7.62B 10.0x 1.0x
Bio-Rad Laboratories, Inc. BIO-B ██% $8.56B 24.6x 1.3x
Bionano Genomics, Inc. BNGO ██% $12M 0.0x 0.2x
Bruker Corp BRKR ██% $6.06B 74.6x 2.5x
Cytek Biosciences, Inc. CTKB ██% $569M 82.0x 1.7x
Eyepoint, Inc. EYPT ██% $1.52B -4.4x 7.6x
Harvard Bioscience Inc HBIO ██% $26M -8.3x 1.9x
Illumina, Inc. ILMN ██% $20.33B 23.9x 7.5x
Standard Biotools Inc. LAB ██% $422M -2.4x 1.1x
Lifeloc Technologies, Inc LCTC ██% $6M x 1.1x
Mettler Toledo International Inc/ MTD ██% $27.82B 31.5x 1122.3x
Nautilus Biotechnology, Inc. NAUT ██% $359M -3.8x 2.1x
Pacific Biosciences Of California, Inc. PACB ██% $507M -1.5x 94.8x
Precipio, Inc. PRPO ██% $42M -1.2x 2.9x
Quanterix Corp QTRX ██% $268M -11.1x 0.9x
Rapid Micro Biosystems, Inc. RPID ██% $193M -0.9x 4.4x
Revvity, Inc. RVTY ██% $11.04B 45.8x 1.5x
Scientific Industries Inc SCND ██% $9M x 0.7x
Seer, Inc. SEER ██% $104M -2.0x 0.3x
10x Genomics, Inc. TXG ██% $2.95B -8.6x 3.7x
Waters Corp /De/ WAT ██% $31.33B 48.8x 12.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Rapid Micro Biosystems, Inc. Stock Forecast

How accurate are Rapid Micro Biosystems, Inc. stock predictions?

Our AI model shows a -12% Spearman correlation coefficient for RPID predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Rapid Micro Biosystems, Inc. stock price forecasts?

Our analysis considers Rapid Micro Biosystems, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Rapid Micro Biosystems, Inc. a good investment in 2025?

Based on our AI analysis, Rapid Micro Biosystems, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Rapid Micro Biosystems, Inc. forecasts updated?

Rapid Micro Biosystems, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...